AU2003202753A1 - Oxazolidinone derivatives as antimicrobials - Google Patents

Oxazolidinone derivatives as antimicrobials

Info

Publication number
AU2003202753A1
AU2003202753A1 AU2003202753A AU2003202753A AU2003202753A1 AU 2003202753 A1 AU2003202753 A1 AU 2003202753A1 AU 2003202753 A AU2003202753 A AU 2003202753A AU 2003202753 A AU2003202753 A AU 2003202753A AU 2003202753 A1 AU2003202753 A1 AU 2003202753A1
Authority
AU
Australia
Prior art keywords
antimicrobials
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003202753A
Other languages
English (en)
Inventor
Anita Mehta
Ajjarapu Venkata Subrahmanya Raja Rao
Ashok Rattan
Sonali Rudra
Ajay Singh Yadav
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2003202753A1 publication Critical patent/AU2003202753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003202753A 2003-02-07 2003-02-07 Oxazolidinone derivatives as antimicrobials Abandoned AU2003202753A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2003/000429 WO2004069816A1 (fr) 2003-02-07 2003-02-07 Derives d'oxazolidinones en tant qu'agents anitmicrobiens

Publications (1)

Publication Number Publication Date
AU2003202753A1 true AU2003202753A1 (en) 2004-08-30

Family

ID=32843789

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202753A Abandoned AU2003202753A1 (en) 2003-02-07 2003-02-07 Oxazolidinone derivatives as antimicrobials

Country Status (3)

Country Link
EP (1) EP1594852A1 (fr)
AU (1) AU2003202753A1 (fr)
WO (1) WO2004069816A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (fr) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibiotiques a action duale renfermant une oxazolidinone et une quinolone ou une fraction de naphthyridinone
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
ES2308171T3 (es) 2003-04-30 2008-12-01 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
PL1709044T5 (pl) 2003-12-18 2014-03-31 Morphochem Aktiengesellschaft Fuer Komb Chemie Antybiotyki hybrydowe oksazolidynon-chinolon
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
CA2578016A1 (fr) * 2004-09-01 2006-03-09 Pfizer Products Inc. Antagonistes des recepteurs d'amine histamine-3 azabicycliques
AU2006331882A1 (en) * 2005-12-21 2007-07-05 Schering Corporation Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
JP5209254B2 (ja) * 2007-08-30 2013-06-12 日本曹達株式会社 置換フェノキシアザビシクロオクタン誘導体の製造方法
KR101712679B1 (ko) * 2008-10-27 2017-03-22 미쓰비시 타나베 파마 코퍼레이션 신규 아미드 유도체 및 이의 의약으로서의 용도
WO2011136292A1 (fr) 2010-04-27 2011-11-03 田辺三菱製薬株式会社 Nouveau dérivé d'amide et emploi dudit dérivé au titre de médicament
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代２－氮雜雙環類及其作為食慾素受體調控劑之用途
NZ730334A (en) 2014-09-11 2023-01-27 Janssen Pharmaceutica Nv Substituted 2-azabicycles and their use as orexin receptor modulators
WO2023061617A1 (fr) * 2020-12-21 2023-04-20 F. Hoffmann-La Roche Ag Composés de sulfonylpipérazinyle pour le traitement d'infections bactériennes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518285B2 (en) * 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
SK1402003A3 (en) * 2000-07-17 2003-08-05 Ranbaxy Lab Ltd Oxazolidinone derivatives as antimicrobials
EP1409464A4 (fr) * 2001-07-16 2005-11-02 Ranbaxy Lab Ltd Derives d'oxazolidinone utilises comme antimicrobiens potentiels

Also Published As

Publication number Publication date
WO2004069816A1 (fr) 2004-08-19
EP1594852A1 (fr) 2005-11-16

Similar Documents

Publication Publication Date Title
AU2003295113A1 (en) Oxazolidinone derivatives as antibacterial
EP1606277B8 (fr) Derives de l'imidazol-4-yl-ethynyl-pyridine
AU2003272930A1 (en) Footwere
AU2002319848A1 (en) Oxazolidinone derivatives as antimicrobials
AU2003202753A1 (en) Oxazolidinone derivatives as antimicrobials
AU2002258054A1 (en) Oxazolidinone derivatives as antimicrobials
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
EP1706373B8 (fr) Derives d'amidoacetonitrile
AU2003292426A1 (en) Oxazolidinone derivatives as antibacterial agents
AU2003215861A1 (en) Oxazolidinone derivatives as antimicrobials
AU2003223034A1 (en) Oxazolidinone derivatives as antimicrobials
AU2003292420A1 (en) Antibacterial oxazolidinones
AU2003274573A1 (en) Deburrer
AU2003100144A4 (en) Lousicide composition
AU2003241210A1 (en) Videocomputer
AU2003228008A1 (en) Oxazolidinone derivatives as antibacterial agents
AU2003281526A1 (en) Oxazolidinone derivatives as antibacterial agents
AU2002219458A1 (en) Oxazolidinone derivatives as potential antimicrobials
AU2003226645A1 (en) Microbial decontaminator
AU2003280821A1 (en) Beauveriolide derivative
AU2003236366A1 (en) Oxazolidinone derivatives
AU2003280822A1 (en) Beauveriolide derivatives
AU2003900127A0 (en) Aminoalcohol derivatives
AU2003907111A0 (en) Aminoalcohol Derivatives
AU2002355666A1 (en) Oxazolidinone derivatives as antibacterial agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase